Papke RL - Search Results

1

Activation and inhibition of rat neuronal nicotinic receptors by ABT-418.

Papke RL, Thinschmidt JS, Moulton BA, Meyer EM, Poirier A. Papke RL, et al. Br J Pharmacol. 1997 Feb;120(3):429-38. doi: 10.1038/sj.bjp.0700930. Br J Pharmacol. 1997. PMID: 9031746 Free PMC article.

2

Characterization of a series of anabaseine-derived compounds reveals that the 3-(4)-dimethylaminocinnamylidine derivative is a selective agonist at neuronal nicotinic alpha 7/125I-alpha-bungarotoxin receptor subtypes.

de Fiebre CM, Meyer EM, Henry JC, Muraskin SI, Kem WR, Papke RL. de Fiebre CM, et al. Among authors: papke rl. Mol Pharmacol. 1995 Jan;47(1):164-71. Mol Pharmacol. 1995. PMID: 7838125

3

A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus.

Hunter BE, de Fiebre CM, Papke RL, Kem WR, Meyer EM. Hunter BE, et al. Among authors: papke rl. Neurosci Lett. 1994 Feb 28;168(1-2):130-4. doi: 10.1016/0304-3940(94)90433-2. Neurosci Lett. 1994. PMID: 8028765

4

Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit.

Papke RL, Heinemann SF. Papke RL, et al. Mol Pharmacol. 1994 Jan;45(1):142-9. Mol Pharmacol. 1994. PMID: 8302273

5

Differentiation of ionic currents in CNS progenitor cells: dependence upon substrate attachment and epidermal growth factor.

Feldman DH, Thinschmidt JS, Peel AL, Papke RL, Reier PJ. Feldman DH, et al. Among authors: papke rl. Exp Neurol. 1996 Aug;140(2):206-17. doi: 10.1006/exnr.1996.0130. Exp Neurol. 1996. PMID: 8690063

6

An evaluation of neuronal nicotinic acetylcholine receptor activation by quaternary nitrogen compounds indicates that choline is selective for the alpha 7 subtype.

Papke RL, Bencherif M, Lippiello P. Papke RL, et al. Neurosci Lett. 1996 Aug 9;213(3):201-4. doi: 10.1016/0304-3940(96)12889-5. Neurosci Lett. 1996. PMID: 8873149

7

Muscle-type nicotinic acetylcholine receptor delta subunit determines sensitivity to noncompetitive inhibitors, while gamma subunit regulates divalent permeability.

Francis MM, Papke RL. Francis MM, et al. Among authors: papke rl. Neuropharmacology. 1996;35(11):1547-56. doi: 10.1016/s0028-3908(96)00103-7. Neuropharmacology. 1996. PMID: 9025102

8

3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner.

Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, de Fiebre CM. Meyer EM, et al. Among authors: papke rl. Brain Res. 1997 Sep 12;768(1-2):49-56. doi: 10.1016/s0006-8993(97)00536-2. Brain Res. 1997. PMID: 9369300

9

Anabaseine is a potent agonist on muscle and neuronal alpha-bungarotoxin-sensitive nicotinic receptors.

Kem WR, Mahnir VM, Papke RL, Lingle CJ. Kem WR, et al. Among authors: papke rl. J Pharmacol Exp Ther. 1997 Dec;283(3):979-92. J Pharmacol Exp Ther. 1997. PMID: 9399967

10

Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties.

Meyer EM, Tay ET, Zoltewicz JA, Meyers C, King MA, Papke RL, De Fiebre CM. Meyer EM, et al. Among authors: papke rl. J Pharmacol Exp Ther. 1998 Mar;284(3):1026-32. J Pharmacol Exp Ther. 1998. PMID: 9495863

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

182 results

Search Page

Filters